Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  United Therapeutics Corporation    UTHR   US91307C1027

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. operates as a biotechnology company, which focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

The company operates in two business segments: Pharmaceuticals and Telemedicine.

Its primary product Remodulin is used for the treatment of pulmonary arterial hypertension and the company also develops glycol-biological antiviral agents for the treatment of infectious diseases, such as Hepatitis C. United Therapeutics was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 740 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,117100%1,289100% +13.31%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States1,03292.4%1,18191.6% +12.56%
Rest-of-World84.557.6%107.768.4% +21.54%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA601996Chairman & Co-Chief Executive Officer
Roger A. Jeffs, PhD531998President, Co-Chief Executive Officer & Director
David Zaccardelli, PhD502004Chief Operating Officer & Executive Vice President
James Edgemond472013Chief Financial Officer & Treasurer
Shola Oyewole-2000Chief Information Officer
Raymond C. Kurzweil, PhD662002Director
Louis Wade Sullivan, MD802013Independent Director
Raymond Allen Dwek722002Non-Independent Director
Christopher Patusky502002Vice Chairman
Christopher Causey, MBA512003Independent Director
Shareholders
NameShares%
Fidelity Management & Research Co. 4,380,334 9.48%
BlackRock Fund Advisors 3,506,113 7.59%
The Vanguard Group, Inc. 3,161,383 6.84%
Scopia Capital Management LLC 2,415,686 5.23%
LSV Asset Management 1,966,736 4.26%
BlackRock Advisors LLC 1,852,324 4.01%
Acadian Asset Management LLC 1,564,129 3.38%
Iridian Asset Management LLC 1,448,124 3.13%
Palo Alto Investors LLC 1,429,928 3.09%
SSgA Funds Management, Inc. 1,374,589 2.97%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
ALNYLAM PHARMACEU..
ALKERMES PLC
QUINTILES TRANSNA..
UNITED THERAPEUTI..
CELLTRION, INC.
QIAGEN NV
ISIS PHARMACEUTIC..
ANACOR PHARMACEUT..
SEATTLE GENETICS,..
INTREXON CORP
ACADIA PHARMACEUT..
BIO-TECHNE CORP
ICON PLC
BB BIOTECH AG
PAREXEL INTERNATI..
CHARLES RIVER LAB..
NOVAVAX, INC.
WUXI PHARMATECH (..
HANGZHOU TIGERMED..
Sector Biotechnology & Medical Research
United Therapeutics Corpor : Connections
Kurzweil Technologies, Inc.
Patusky Associates LLC
LifeF/X, Inc.
FatKat, Inc.
Medical Learning Co., Inc.
X PRIZE Foundation
Synthetic Genomics, Inc.
Project HOPE-The-People-To-People HealthFoundation, Inc.
University of Oxford
Morehouse School of Medicine
The Sullivan Alliance
Oxford Glycobiology Institute
Public Broadcasting Atlanta
Slater Run Vineyards LLC
Association of Public Television Stations
Causey Consortium
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
© 2015 People , Fundamentals and Ownership